About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,708 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,708 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3181-3200 of 13,708 trials

CompletedEfficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)This study will evaluate the safety and efficacy of combination therapy of lenvatinib (E7080/MK-7902) and pembrolizumab following approximately 2 years of pembrolizumab therapy…NCT03776136·Chandler, Arizona and 22 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

TerminatedA 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerA Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.NCT01709734·Los Angeles, California and 22 others

TerminatedOpen-label Trial of Leukine in Active Crohn's DiseaseThe purpose of this study is to establish a safety profile sargramostim administered in 8 week cycles to adult patients with active Crohn's disease.NCT00206700·Birmingham, Alabama and 166 others

CompletedGenetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving ChemotherapyRATIONALE: Genetic testing may help predict how patients will respond to chemotherapy drugs and may help doctors plan more effective treatment with fewer side effects.NCT00048971·Anniston, Alabama and 83 others

CompletedEfficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer RecurrencePurpose of this trial: 1. To assess the efficacy and safety of NeuVax™ administered with adjuvant Leukine® (sargramostim, GM-CSF).NCT01479244·Bessemer, Alabama and 196 others

CompletedCTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1The study is a 2-arm, multicenter, 1:1 randomized, placebo controlled clinical trial. All subjects will receive close monitoring for development of AGT or T1DM.NCT01773707·San Francisco, California and 16 others

CompletedA Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin LymphomaThis study is a Phase 1/2 open-label three part study in patients with relapsed indolent Non-Hodgkin's lymohoma (NHL) (Parts A and C) or relapsed/refractory follicular lymphoma…NCT01796171·Little Rock, Arkansas and 95 others

CompletedA Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyThe purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.NCT02973100·Glendale, California and 65 others

Active not recruitingBio-Banking of Specimens for Advanced Lung Disease and Lung Transplant ResearchA major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and…NCT04664192·Dallas, Texas

TerminatedMM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsThis study is an open label, randomized, multicenter trial of MM-302 plus trastuzumab.NCT02213744·Glendale, Arizona and 108 others

CompletedInfant Aphakia Treatment Study (IATS)The primary purpose is to determine whether infants with a unilateral congenital cataract are more likely to develop better vision following cataract extraction surgery if they…NCT00212134·Palo Alto, California and 12 others

CompletedAxitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell CancerThe study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer after failure…NCT00678392·Burbank, California and 293 others

RecruitingA Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)This is a multi-center, randomized, two-part (Part A and Part B) study investigating the safety and efficacy of efimosfermin alfa in adult participants with compensated cirrhosis…NCT07704892·Little Rock, Arkansas and 19 others

TerminatedHigh Flow Nasal Cannula (HFNC) Initiation Flow Rate StudyThe investigators propose an open label, non-blinded, single center randomized controlled feasibility study to find the optimal initial HFNC flow rate in children less than 12…NCT04517344·Dallas, Texas

CompletedA Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)The main research hypothesis for this study is that, among patients with Major Depressive Disorder (MDD) who have responded inadequately to treatment with SSRIs or SNRIs, the…NCT01318434·Arcadia, California and 42 others

TerminatedLong-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderThe purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compulsive disorder (OCD).NCT04708834·Chandler, Arizona and 174 others

Active not recruitingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a…NCT04625647·Birmingham, Alabama and 828 others

CompletedHOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ RecipientsThe primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complicationsNCT03734393·Birmingham, Alabama and 25 others

CompletedGeneric Database of Moderate Preterm InfantsThis is a registry of moderate preterm infants, born alive at 29-33 weeks gestational age, in NICHD Neonatal Research Network (NRN) centers.NCT01793116·Birmingham, Alabama and 18 others

TerminatedComparative Analysis of Virtuos and Autograft in Lumbar FusionCompare the lumbar fusion rates at 12 and 24 months when lumbar arthrodesis is performed using Virtuos or Autograft Bone Graft.NCT05614284·New Britain, Connecticut and 2 others

PreviousPage 160 of 686Next

Heart Diseasein Dallas